Behandlungsrichtlinien spielen Abhängigkeitsthematik und Absetzprobleme herunter
Verfasst: 27.11.2015 18:38
Justin Karter von MIA fasst zusammen:
A review of treatment guidelines published in Psychotherapy and Psychosomatics found that guidelines “shy away from stating clearly that SSRIs/SNRIs, like BDZs, are often (though not always) associated with pharmacological dependence, which is manifested through the withdrawal symptoms during their discontinuation.”
http://www.madinamerica.com/2015/11/tre ... ependence/
Eine weitere Zusammenfassung gibt es hier:
http://www.medicalnewstoday.com/releases/302588.php
Der Volltext ist (noch) nicht aufrufbar.
http://www.karger.com/Article/Abstract/439137
A review of treatment guidelines published in Psychotherapy and Psychosomatics found that guidelines “shy away from stating clearly that SSRIs/SNRIs, like BDZs, are often (though not always) associated with pharmacological dependence, which is manifested through the withdrawal symptoms during their discontinuation.”
http://www.madinamerica.com/2015/11/tre ... ependence/
Eine weitere Zusammenfassung gibt es hier:
http://www.medicalnewstoday.com/releases/302588.php
Der Volltext ist (noch) nicht aufrufbar.
http://www.karger.com/Article/Abstract/439137